FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

318585008: Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    2153207013 Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    2160838018 Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule en Synonym Active Entire term case insensitive SNOMED CT core module
    46612301000001112 Propranolol 160mg modified-release / Bendroflumethiazide 5mg capsules en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Is a Propranolol+diuretic false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has active ingredient Diuretic false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has active ingredient Propranolol false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Is a Propranolol hydrochloride + bendrofluazide false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has active ingredient Propranolol hydrochloride false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has active ingredient Bendrofluazide - chemical false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Is a Product containing bendroflumethiazide and propranolol false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has manufactured dose form Conventional release oral capsule false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has manufactured dose form Modified-release oral capsule false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Is a Product containing propranolol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has manufactured dose form Modified-release capsule false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has manufactured dose form Modified-release oral capsule false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has manufactured dose form Modified-release oral capsule false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has specific active ingredient Propranolol hydrochloride false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has specific active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Has dispensed dose form Modified-release oral capsule false Inferred relationship Existential restriction modifier
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Propranolol hydrochloride+bendrofluazide 160mg/5mg m/r capsule - product Is a False Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Inferred relationship Existential restriction modifier
    Inderex 160mg/5mg modified-release capsules (AstraZeneca) Is a False Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Inferred relationship Existential restriction modifier
    Propranolol 160mg modified-release / Bendroflumethiazide 5mg capsules 28 capsule Is pack of False Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Inferred relationship Existential restriction modifier
    Propranolol 160mg modified-release / Bendroflumethiazide 5mg capsules 28 capsule Has VMP False Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start